Groups | Mean Difference (X-Y) | P-value | 95% Confidence Interval | |||
---|---|---|---|---|---|---|
Lower | Upper | |||||
Post-operative Hb (gm/dl) | Control (X) | Tranexamic (Y) | -0.50 | < 0.001* | -0.808 | -0.192 |
Misoprostol (Y) | -0.70 | < 0.001* | -1.004 | -0.388 | ||
Tranexamic (X) | Control (Y) | 0.50 | < 0.001* | 0.192 | 0.808 | |
Misoprostol (Y) | -0.20 | 0.294 | -0.504 | 0.112 | ||
Misoprostol (X) | Control (Y) | 0.70 | < 0.001* | 0.388 | 1.004 | |
Tranexamic (Y) | 0.20 | 0.294 | -0.112 | 0.504 | ||
Hb difference (gm/dl) | Control (X) | Tranexamic (Y) | -0.54 | < 0.001* | -0.708 | -0.363 |
Misoprostol (Y) | -0.49 | < 0.001* | -0.659 | -0.314 | ||
Tranexamic (X) | Control (Y) | 0.54 | < 0.001* | 0.363 | 0.708 | |
Misoprostol (Y) | 0.05 | 0.779 | -0.123 | 0.222 | ||
Misoprostol (X) | Control (Y) | 0.49 | < 0.001* | 0.314 | 0.659 | |
Tranexamic (Y) | -0.05 | 0.779 | -0.222 | 0.123 | ||
Post-operative HCT (%) | Control (X) | Tranexamic (Y) | -1.39 | 0.002 | -2.333 | -0.446 |
Misoprostol (Y) | -2.12 | < 0.001* | -3.063 | -1.175 | ||
Tranexamic (X) | Control (Y) | 1.39 | 0.002 | 0.446 | 2.333 | |
Misoprostol (Y) | -0.73 | 0.165 | -1.673 | 0.214 | ||
Misoprostol (X) | Control (Y) | 2.12 | < 0.001* | 1.175 | 3.063 | |
Tranexamic (Y) | 0.73 | 0.165 | -0.214 | 1.673 | ||
HCT difference (%) | Control (X) | Tranexamic (Y) | -1.89 | < 0.001* | -2.342 | -1.446 |
Misoprostol (Y) | -1.89 | < 0.001* | -2.334 | -1.438 | ||
Tranexamic (X) | Control (Y) | 1.89 | < 0.001* | 1.446 | 2.342 | |
Misoprostol (Y) | 0.01 | 0.999 | -0.440 | 0.456 | ||
Misoprostol (X) | Control (Y) | 1.89 | < 0.001* | 1.438 | 2.334 | |
Tranexamic (Y) | -0.01 | 0.999 | -0.456 | 0.440 | ||
Estimated blood loss (ml) | Control (X) | Tranexamic (Y) | 360.74 | < 0.001* | 274.219 | 447.260 |
Misoprostol (Y) | 384.43 | < 0.001* | 297.914 | 470.955 | ||
Tranexamic (X) | Control (Y) | -360.74 | < 0.001* | -447.260 | -274.219 | |
Misoprostol (Y) | 23.70 | 0.795 | -62.825 | 110.216 | ||
Misoprostol (X) | Control (Y) | -384.43 | < 0.001* | -470.955 | -297.914 | |
Tranexamic (Y) | -23.70 | 0.795 | -110.216 | 62.825 | ||
Blood loss in suction apparatus (ml) | Control (X) | Tranexamic (Y) | 147.83 | < 0.001* | 110.948 | 184.704 |
Misoprostol (Y) | 146.52 | < 0.001* | 109.644 | 183.399 | ||
Tranexamic (X) | Control (Y) | -147.83 | < 0.001* | -184.704 | -110.948 | |
Misoprostol (Y) | -1.30 | 0.996 | -38.182 | 35.573 | ||
Misoprostol (X) | Control (Y) | -146.52 | < 0.001* | -183.399 | -109.644 | |
Tranexamic (Y) | 1.30 | 0.996 | -35.573 | 38.182 |